Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin C Collins

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
Nucleic Acids Research|February 14, 2019
Structural variation and fusion detection using targeted sequencing data from circulating cell free DNAAlexander R Gawroński, Yen-Yi Lin, Brian McConeghy, et al.
Molecular Oncology|February 19, 2019
The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional programAbhijit Parolia, Erik Venalainen, Hui Xue, et al.
International Journal of Cancer|October 10, 2020
GRB10 sustains AR activity by interacting with PP2A in prostate cancer cellsJun Hao, Xinpei Ci, Yong Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2017
Mutational Analysis of Gene Fusions Predicts Novel MHC Class I-Restricted T-Cell Epitopes and Immune Signatures in a Subset of Prostate CancerJennifer L Kalina, David S Neilson, Yen-Yi Lin, et al.
Nature Genetics|October 2, 2002
Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumorsGiuseppe Zardo, Maarit I Tiirikainen, Chibo Hong, et al.
Bioinformatics (Oxford, England)|August 18, 2016
SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNACan Kockan, Faraz Hach, Iman Sarrafi, et al.
Bioinformatics (Oxford, England)|April 5, 2018
MechRNA: prediction of lncRNA mechanisms from RNA-RNA and RNA-protein interactionsAlexander R Gawronski, Michael Uhl, Yajia Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
<i>BIRC6</i> Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate CancerIris Sze Ue Luk, Raunak Shrestha, Hui Xue, et al.
Cancer Cell International|January 15, 2019
Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic targetMarta Llaurado Fernandez, Amy Dawson, Joshua Hoenisch, et al.
Urologic Oncology|June 19, 2016
Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancerEdmund C P Chedgy, James Douglas, Jonathan L Wright, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Nucleic Acids Research|February 14, 2019
Structural variation and fusion detection using targeted sequencing data from circulating cell free DNAAlexander R Gawroński, Yen-Yi Lin, Brian McConeghy, et al.
Molecular Oncology|February 19, 2019
The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional programAbhijit Parolia, Erik Venalainen, Hui Xue, et al.
International Journal of Cancer|October 10, 2020
GRB10 sustains AR activity by interacting with PP2A in prostate cancer cellsJun Hao, Xinpei Ci, Yong Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2017
Mutational Analysis of Gene Fusions Predicts Novel MHC Class I-Restricted T-Cell Epitopes and Immune Signatures in a Subset of Prostate CancerJennifer L Kalina, David S Neilson, Yen-Yi Lin, et al.
Nature Genetics|October 2, 2002
Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumorsGiuseppe Zardo, Maarit I Tiirikainen, Chibo Hong, et al.
Bioinformatics (Oxford, England)|August 18, 2016
SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNACan Kockan, Faraz Hach, Iman Sarrafi, et al.
Bioinformatics (Oxford, England)|April 5, 2018
MechRNA: prediction of lncRNA mechanisms from RNA-RNA and RNA-protein interactionsAlexander R Gawronski, Michael Uhl, Yajia Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
<i>BIRC6</i> Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate CancerIris Sze Ue Luk, Raunak Shrestha, Hui Xue, et al.
Cancer Cell International|January 15, 2019
Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic targetMarta Llaurado Fernandez, Amy Dawson, Joshua Hoenisch, et al.
Urologic Oncology|June 19, 2016
Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancerEdmund C P Chedgy, James Douglas, Jonathan L Wright, et al.
Pageof 10